Skip to main content

Advertisement

Log in

Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis

  • Breast
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To investigate the impact of background parenchymal enhancement (BPE), amount of fibroglandular tissue (FGT) and menopausal status on apparent diffusion coefficient (ADC) values in differentiation between malignant and benign lesions.

Methods

In this HIPAA-compliant study, mean ADC values of 218 malignant and 130 benign lesions from 288 patients were retrospectively evaluated. The differences in mean ADC values between benign and malignant lesions were calculated within groups stratified by BPE level (high/low), amount of FGT (dense/non-dense) and menopausal status (premenopausal/postmenopausal). Sensitivities and specificities for distinguishing malignant from benign lesions within different groups were compared for statistical significance.

Results

The mean ADC value for malignant lesions was significantly lower compared to that for benign lesions (1.07±0.21 x 10−3 mm2/s vs. 1.53±0.26 x 10−3 mm2/s) (p<0.0001). Using the optimal cut-off point of 1.30 x 10−3 mm2/s, an area under the curve of 0.918 was obtained, with sensitivity and specificity both of 87 %. There was no statistically significant difference in sensitivities and specificities of ADC values between different groups stratified by BPE level, amount of FGT or menopausal status.

Conclusions

Differentiation between benign and malignant lesions on ADC values is not significantly affected by BPE level, amount of FGT or menopausal status.

Key Points

ADC allows differentiation between benign and malignant lesions.

ADC is useful for breast cancer diagnosis despite different patient characteristics.

BPE, FGT or menopause do not significantly affect sensitivity and specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ADC:

Apparent diffusion coefficient

AUC:

Area under the curve

BIRADS:

Breast Imaging Reporting and Data System

BPE:

Background parenchymal enhancement

DWI:

Diffusion-weighted imaging

DCE:

Dynamic contrast-enhancement

FGT:

Fibroglandular tissue

MRI:

Magnetic resonance imaging

ROC:

Receiving operator characteristic

SD:

Standard deviation

References

  1. Mann RM, Balleyguier C, Baltzer PA et al (2015) Breast MRI: EUSOBI recommendations for women's information. Eur Radiol 25:3669–3678

    Article  PubMed  PubMed Central  Google Scholar 

  2. Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316

    Article  PubMed  Google Scholar 

  3. Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S (2017) Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer. Radiology 283:361–370

    Article  PubMed  Google Scholar 

  4. Lehman CD, Smith RA (2009) The role of MRI in breast cancer screening. J Natl Compr Canc Netw 7:1109–1115

    Article  PubMed  Google Scholar 

  5. Lourenco AP, Donegan L, Khalil H, Mainiero MB (2014) Improving outcomes of screening breast MRI with practice evolution: initial clinical experience with 3T compared to 1.5T. J Magn Reson Imaging 39:535–539

    Article  PubMed  Google Scholar 

  6. Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD (2009) Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 193:1716–1722

    Article  PubMed  Google Scholar 

  7. Pinker K, Helbich TH, Morris EA (2017) The potential of multiparametric MRI of the breast. Br J Radiol 90:20160715

    Article  PubMed  Google Scholar 

  8. European Society of R (2010) White paper on imaging biomarkers. Insights Imaging 1:42–45

    Article  Google Scholar 

  9. Tan SL, Rahmat K, Rozalli FI et al (2014) Differentiation between benign and malignant breast lesions using quantitative diffusion-weighted sequence on 3 T MRI. Clin Radiol 69:63–71

    Article  CAS  PubMed  Google Scholar 

  10. Guo Y, Cai YQ, Cai ZL et al (2002) Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 16:172–178

    Article  PubMed  Google Scholar 

  11. White NS, McDonald CR, Farid N et al (2014) Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging. Cancer Res 74:4638–4652

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Matsubayashi RN, Fujii T, Yasumori K, Muranaka T, Momosaki S (2010) Apparent diffusion coefficient in invasive ductal breast carcinoma: correlation with detailed histologic features and the enhancement ratio on dynamic contrast-enhanced MR images. J Oncol 2010:1–6. https://www.hindawi.com/journals/jo/2010/821048/

  13. Martincich L, Deantoni V, Bertotto I et al (2012) Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 22:1519–1528

    Article  PubMed  Google Scholar 

  14. Arlinghaus LR, Li X, Rahman AR et al (2011) On the relationship between the apparent diffusion coefficient and extravascular extracellular volume fraction in human breast cancer. Magn Reson Imaging 29:630–638

    Article  PubMed  PubMed Central  Google Scholar 

  15. Partridge SC, Mullins CD, Kurland BF et al (2010) Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 194:1664–1673

    Article  PubMed  Google Scholar 

  16. Caivano R, Villonio A, D’ Antuono F et al (2015) Diffusion weighted imaging and apparent diffusion coefficient in 3 tesla magnetic resonance imaging of breast lesions. Cancer Invest 33:159–164

    Article  PubMed  Google Scholar 

  17. Suo S, Cheng F, Cao M et al (2017) Multiparametric diffusion-weighted imaging in breast lesions: Association with pathologic diagnosis and prognostic factors. J Magn Reson Imaging 46:740–750

    Article  PubMed  Google Scholar 

  18. Tsushima Y, Takahashi-Taketomi A, Endo K (2009) Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging 30:249–255

    Article  PubMed  Google Scholar 

  19. Kul S, Eyuboglu I, Cansu A, Alhan E (2014) Diagnostic efficacy of the diffusion weighted imaging in the characterization of different types of breast lesions. J Magn Reson Imaging 40:1158–1164

    Article  PubMed  Google Scholar 

  20. Ei Khouli RH, Jacobs MA, Mezban SD et al (2010) Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging. Radiology 256:64–73

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kim JY, Suh HB, Kang HJ et al (2016) Apparent diffusion coefficient of breast cancer and normal fibroglandular tissue in diffusion-weighted imaging: the effects of menstrual cycle and menopausal status. Breast Cancer Res Treat 157:31–40

    Article  CAS  PubMed  Google Scholar 

  22. Cho GY, Moy L, Kim SG et al (2015) Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue. Eur J Radiol 84:1888–1893

    Article  PubMed  Google Scholar 

  23. Choi YJ, Chen JH, Yu HJ, Li Y, Su MY (2017) Impact of Different Analytic Approaches on the Analysis of the Breast Fibroglandular Tissue Using Diffusion Weighted Imaging. Biomed Res Int 2017:1094354

    PubMed  PubMed Central  Google Scholar 

  24. Clendenen TV, Kim S, Moy L et al (2013) Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magn Reson Imaging 31:1–9

    Article  CAS  PubMed  Google Scholar 

  25. Iacconi C, Thakur SB, Dershaw DD, Brooks J, Fry CW, Morris EA (2014) Impact of fibroglandular tissue and background parenchymal enhancement on diffusion weighted imaging of breast lesions. Eur J Radiol 83:2137–2143

    Article  PubMed  Google Scholar 

  26. Kawamura A, Satake H, Ishigaki S et al (2015) Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging. Nagoya J Med Sci 77:425–437

    PubMed  PubMed Central  Google Scholar 

  27. McDonald ES, Schopp JG, Peacock S et al (2014) Diffusion-weighted MRI: association between patient characteristics and apparent diffusion coefficients of normal breast fibroglandular tissue at 3 T. AJR Am J Roentgenol 202:W496–W502

    Article  PubMed  PubMed Central  Google Scholar 

  28. O'Flynn EA, Wilson RM, Allen SD, Locke I, Scurr E, deSouza NM (2014) Diffusion-weighted imaging of the high-risk breast: Apparent diffusion coefficient values and their relationship to breast density. J Magn Reson Imaging 39:805–811

    Article  PubMed  Google Scholar 

  29. Partridge SC, Singer L, Sun R et al (2011) Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements. Magn Reson Imaging 29:1215–1221

    Article  PubMed  PubMed Central  Google Scholar 

  30. Morris EA, Comstock CE, Lee CH, et al. (2013) ACR BI-RADS® magnetic resonance imaging. In: ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. American College of Radiology, Reston, VA

  31. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32–35

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Joanne Chin for technical editing.

Funding

This study has received funding by Memorial Sloan Kettering Cancer Center Support Grant / NIH Core Grant (P30 CA008748), DOD BCRP W81XWH-09-1-0042 grant, and the Breast Cancer Research Foundation grant of Memorial Sloan Kettering Cancer Center.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sunitha B. Thakur.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Sunitha B. Thakur.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

One of the authors has significant statistical expertise (Sujata Patil).

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Study subjects or cohorts overlap

Some study subjects or cohorts have been previously reported in Durando M, Gennaro L, Cho GY et al (2016) Quantitative apparent diffusion coefficient measurement obtained by 3.0Tesla MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer. Eur J Radiol 85:1651-1658. However, different data were used in a different context.

Methodology

• retrospective

• observational

• performed at one institution

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horvat, J.V., Durando, M., Milans, S. et al. Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis. Eur Radiol 28, 2516–2524 (2018). https://doi.org/10.1007/s00330-017-5202-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-017-5202-4

Keywords

Navigation